Ticker Scorecard - QURE Basics Company: uniQure N.V. Ordinary Shares IPO Date: March 1, 2014 Sector: Healthcare Industry: Biotech Market Cap: $625.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 2.86% Avg Daily Range (30 D): $0.47 | 3.09% Avg Daily Range (90 D): $0.40 | 3.68% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): 1.55M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 103 Institutional Trades Total Inst.Trades: 2,267 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.24M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.8M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 88.85K     News Feb 7, 2025 @ 2:12 PM CSL Behring's Gene Therapy HEMGENIX® (etranacog... Source: Prnewswire Jan 7, 2025 @ 9:49 PM uniQure Announces Proposed Public Offering Source: N/A Aug 30, 2024 @ 12:59 PM Gene Therapy Market Size to Reach USD 54.39 Billio... Source: Sns Insider Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor Jul 9, 2024 @ 4:11 PM Crude Oil Down 1%; Soligenix Shares Surge - Helen ... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-4.95 $-.91 $-1.16 Diluted EPS $-4.95 $-.91 $-1.16 Revenue $ 28.59M $ 2.29M $ 11.13M Gross Profit $ $ 2.02M $ 10.89M Net Income / Loss $ -239.5M $ -44.38M $ -56.3M Operating Income / Loss $ -200.21M $ -40.23M $ -44.01M Cost of Revenue $ $ .26M $ .23M Net Cash Flow $ 20.44M $ -37.96M $ 44.77M PE Ratio